BSE Live
Jan 27, 10:54Prev. Close
4070.45
Open Price
4058.20
Bid Price (Qty.)
4057.60 (4)
Offer Price (Qty.)
4072.00 (3)
NSE Live
Jan 27, 10:54Prev. Close
4065.80
Open Price
4079.00
Bid Price (Qty.)
4063.40 (1)
Offer Price (Qty.)
4068.00 (1)
| Balance Sheet of Sanofi India (in Rs. Cr.) | Dec 04 | |
| 12 mths | ||
| EQUITIES AND LIABILITIES | ||
| SHAREHOLDER'S FUNDS | ||
| Equity Share Capital | 23.03 | |
| Total Share Capital | 23.03 | |
| Reserves and Surplus | 380.99 | |
| Total Reserves and Surplus | 398.80 | |
| Total Shareholders Funds | 421.83 | |
| NON-CURRENT LIABILITIES | ||
| Long Term Borrowings | 19.60 | |
| Deferred Tax Liabilities [Net] | 0.00 | |
| Other Long Term Liabilities | 0.00 | |
| Long Term Provisions | 0.00 | |
| Total Non-Current Liabilities | 19.60 | |
| CURRENT LIABILITIES | ||
| Short Term Borrowings | 0.00 | |
| Trade Payables | 40.32 | |
| Other Current Liabilities | 57.11 | |
| Short Term Provisions | 32.55 | |
| Total Current Liabilities | 129.98 | |
| Total Capital And Liabilities | 571.41 | |
| ASSETS | ||
| NON-CURRENT ASSETS | ||
| Tangible Assets | 124.90 | |
| Intangible Assets | 26.76 | |
| Capital Work-In-Progress | 2.79 | |
| Other Assets | 0.00 | |
| Fixed Assets | 154.45 | |
| Non-Current Investments | 5.29 | |
| Deferred Tax Assets [Net] | 0.53 | |
| Long Term Loans And Advances | 0.00 | |
| Other Non-Current Assets | 0.00 | |
| Total Non-Current Assets | 160.27 | |
| CURRENT ASSETS | ||
| Current Investments | 0.00 | |
| Inventories | 101.65 | |
| Trade Receivables | 91.82 | |
| Cash And Cash Equivalents | 167.31 | |
| Short Term Loans And Advances | 50.37 | |
| OtherCurrentAssets | 0.00 | |
| Total Current Assets | 411.14 | |
| Total Assets | 571.41 | |
| OTHER ADDITIONAL INFORMATION | ||
| CONTINGENT LIABILITIES, COMMITMENTS | ||
| Contingent Liabilities | 99.62 | |
| CIF VALUE OF IMPORTS | ||
| Raw Materials | 167.80 | |
| Stores, Spares And Loose Tools | 0.00 | |
| Trade/Other Goods | 0.00 | |
| Capital Goods | 0.97 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||
| Expenditure In Foreign Currency | 16.54 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||
| Dividend Remittance In Foreign Currency | 18.46 | |
| EARNINGS IN FOREIGN EXCHANGE | ||
| FOB Value Of Goods | 192.86 | |
| Other Earnings | 20.40 | |
| BONUS DETAILS | ||
| Bonus Equity Share Capital | 18.38 | |
| NON-CURRENT INVESTMENTS | ||
| Non-Current Investments Quoted Market Value | 1.94 | |
| Non-Current Investments Unquoted Book Value | 5.17 | |
| CURRENT INVESTMENTS | ||
| Current Investments Quoted Market Value | -- | |
| Current Investments Unquoted Book Value | -- |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y